Schettini, F., Conte, B., Buono, G., De Placido, P., Parola, S., Griguolo, G., . . . Del Mastro, L. (2021). T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: An Italian multicenter observational study. ESMO Open.
Citação norma ChicagoSchettini, F., et al. "T-DM1 Versus Pertuzumab, Trastuzumab and a Taxane As First-line Therapy of Early-relapsed HER2-positive Metastatic Breast Cancer: An Italian Multicenter Observational Study." ESMO Open 2021.
Citação norma MLASchettini, F., et al. "T-DM1 Versus Pertuzumab, Trastuzumab and a Taxane As First-line Therapy of Early-relapsed HER2-positive Metastatic Breast Cancer: An Italian Multicenter Observational Study." ESMO Open 2021.